UO Ematologia e CTMO, ASST Spedali Civili Trials

UO Ematologia e CTMO, ASST Spedali Civili	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cattaneo, Chiara

AMELIORATE, NCT04174612 / 2019-003936-21: AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance

Recruiting

172

Europe

Cytarabine, Daunorubicin, Midostaurin, Cytarabine HD

Gruppo Italiano Malattie EMatologiche dell'Adulto, MYNERVA (MYeloid Neoplasms Research Venture AIRC) programma speciale finanziato dall'AIRC - Associazione Italiana per la, Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Franco Mandelli Onlus

Acute Myeloid Leukemia With FLT3/ITD Mutation

12/22

08/25

NCT03250338 / 2017-001600-29: Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Recruiting

322

Europe, Canada, US

Crenolanib, Crenolanib besylate, Cytarabine, Mitoxantrone, Placebo Oral Tablet, Fludarabine, Idarubicin, G-CSF

Arog Pharmaceuticals, Inc.

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

10/24

ALL2418, NCT03610438 / 2018-003006-32: Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Recruiting

Europe

Inotuzumab Ozogamicin (IO)

Gruppo Italiano Malattie EMatologiche dell'Adulto

Acute Lymphoid Leukemia

11/22

NCT04342962 / 2020-001543-94: Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia

Terminated

Europe

tagraxofusp

Gruppo Italiano Malattie EMatologiche dell'Adulto, Stemline Therapeutics, Inc., Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Franco Mandelli Onlus

Acute Myeloid Leukemia

01/24

ALL-IFI, NCT06392581: Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia Patients

Recruiting

N/A

150

Europe

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Acute Lymphoblastic Leukemia

03/24

12/25

EPICOVIDEHA, NCT04733729: Covid-19 in Hematological Malignancies

Recruiting

N/A

3000

Europe

Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne, European Hematology Association

COVID-19 Infection in Hematological Malignancies Patients

09/22

03/24

NCT04352556: COVID19-hematological Malignancies: the Italian Hematology Alliance

Recruiting

N/A

250

Europe

Ospedale di Circolo - Fondazione Macchi

SARS-CoV-2 Infection, Hematological Malignancies

10/22

GIMEMA, NCT06657846: HRQoL and Financial Toxicity in Patients with VEXAS Syndrome

Not yet recruiting

N/A

100

Europe

Gruppo Italiano Malattie EMatologiche dell'Adulto

VEXAS

02/25

06/25

Russo, Domenico

OPTKIMA, NCT02326311: Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response

Completed

229

Europe

imatinib, Glivec, nilotinib, Tasigna, dasatinib, Sprycell

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Leukemia, Chronic Myeloid

12/23

05/24

DEC GITMO, NCT04476199 / 2020-002297-26: Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Active, not recruiting

100

Europe

Venetoclax and Decitabine

Gruppo Italiano Trapianto di Midollo Osseo, Abbvie, Janssen

Acute Myeloid Leukemia

02/23

06/25

POTAMI-61, NCT06397313: RVU120 in Patients with Intermediate or High-risk, Primary or Secondary Myelofibrosis

Recruiting

230

Europe

RVU120, SEL120, Ruxolitinib, RUX

Ryvu Therapeutics SA

Myelofibrosis

06/26

10/27

NCT04352556: COVID19-hematological Malignancies: the Italian Hematology Alliance

Recruiting

N/A

250

Europe

Ospedale di Circolo - Fondazione Macchi

SARS-CoV-2 Infection, Hematological Malignancies

10/22

LNH012, NCT06026644: Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life

Active, not recruiting

N/A

170

Europe

Gruppo Italiano Malattie EMatologiche dell'Adulto

DLBCL - Diffuse Large B Cell Lymphoma

02/24

04/26

NCT03058588: Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

Recruiting

N/A

Europe

Analysis with molecular biology

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Leukemia

12/24

NCT04460950: Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Recruiting

N/A

237

Europe

Gruppo Italiano Malattie EMatologiche dell'Adulto

Acute Myeloid Leukemia, Familial Acute Myeloid Leukemia, Myelodysplastic Syndromes

03/25

NCT05366569: Bio-CAR-T BS Study

Recruiting

N/A

Europe

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), Acute Lymphoblastic Leukemia (ALL)

04/25

04/26



	Diseases Companies Products Productz Mechanisms of Action Sites